Insulin Therapy News

• ISC 2019 SHINE: No Improvement With Intense IV Glucose Control in Stroke Intense intravenous glucose control does not better improve functional outcomes after an ischemic stroke than standard subcutaneous insulin therapy ? and may increase risk for hypoglycemia.
  Medscape Medical News, February 07, 2019
• Switching to Human Insulin Not Harmful in Type 2 Diabetes A health plan program that encouraged Medicare beneficiaries to switch from analog to human insulin didn't increase severe hypoglycemia and only slightly raised average HbA1c.
  Medscape Medical News, January 29, 2019
• Only 20% With Type 1 Diabetes Are Meeting HbA1c Goals Despite increasing use of insulin pumps and continuous glucose monitors, HbA1c levels remain above target for children and adults in a US registry; the problem is even worse among teenagers.
  Medscape Medical News, January 28, 2019
• First-Ever Randomized Trial Shows Oral Insulin Feasibility Although the studied formulation isn't being pursued commercially, trial results are 'trail-blazing' says one expert and demonstrate that a long-acting oral insulin can actually lower blood glucose.
  Medscape Medical News, January 24, 2019
• Why the Reluctance to Use Biosimilar Insulins for Diabetes? As the US FDA announces that it will soon be changing the way it approves biosimilar insulins, Medscape examines why these cheaper versions of branded products are not more widely used in diabetes.
  Medscape Medical News, December 13, 2018
• Fasting for Lab Tests Raises Hypoglycemia Risk in Diabetes Requiring patients with diabetes to fast before routine lab tests may unnecessarily place them at risk for hypoglycemia and possibly dangerous consequences. Authors call for amendment of guidelines.
  Medscape Medical News, December 13, 2018
• Quarter of Insulin Users Skimp Because of Cost: Study Published Newly published study a reminder that a large proportion of US patients with diabetes are cutting back on doses because of cost, a practice often associated with poor glycemic control.
  Medscape Medical News, December 03, 2018
• Endocrine Society Advice on Insulin Dose Adjustment for Libre The Endocrine Society has issued guidance for patients with diabetes on how to use trend arrow data in FreeStyle Libre glucose monitors to adjust insulin following similar advice for Dexcom G5.
  Medscape Medical News, November 27, 2018
• Insulin Need Set to Rise 20% by 2030, but Access May Be Limited Rising prevalence of type 2 diabetes means insulin requirements will increase around the globe, but access needs to improve substantially to meet demand, a mathematical model indicates.
  Medscape Medical News, November 21, 2018
• EASD 2018 System Improves Less-Than-Ideally Controlled Type 1 Diabetes Partially automated insulin delivery system increases time spent in target glucose range and minimizes hypoglycemia in patients with type 1 diabetes who have suboptimal control, but is still far from a cure.
  Medscape Medical News, October 03, 2018
• Alert Possible Pen Needle Confusion Prompts FDA Safety Alert The FDA has received reports of patients using standard pen needles to inject insulin without removing the inner needle cover, leading to patient harm in some cases.
  News Alerts, September 27, 2018
• EASD 2018 It's Personal: EASD Focuses on Individualizing Diabetes Care Providing data for clinicians to help individualize diabetes treatment is one aim of the European Association for the Study of Diabetes (EASD) 2018 Annual Meeting.
  Medscape Medical News, September 24, 2018
• DIY Artificial Pancreas Users Tweet it 'Changes Lives' Study based on use of the #OpenAPS Twitter hashtag suggests that users of the DIY hack of an insulin pump and continuous glucose monitor perceive it as effective, safe, and life changing.
  Medscape Medical News, September 13, 2018
• Majority of Patients in Poorer Nations Not Taking Diabetes Meds Availability, affordability of essential diabetes medicines is still poor in low- and middle-income countries, with a new analysis from PURE indicating only 30% of patients are taking them.
  Medscape Medical News, September 10, 2018
• WHO Issues Cost-Conscious Diabetes Treatment Guidelines World Health Organization guidelines target therapy for type 1 and type 2 diabetes in low-resource settings, differing in several ways from advice of the American College of Physicians.
  Medscape Medical News, September 06, 2018
• ADA Issues New Guidance on Type 1 Diabetes in Youth 'There are unique challenges that children and their families face. We have tried to provide a comprehensive approach to that,' says an author.
  Medscape Medical News, August 10, 2018
• Little Difference Between Basal Insulin Analogs for Type 2 Diabetes Evidence comparing old versus new insulin analogs is poor quality. There are 'many options' and 'high price tags' but 'little ability to discern the potential benefits of one...versus another,' said one commentator.
  Medscape Medical News, July 17, 2018
• Alert Deaths From Fentanyl, Fentanyl Analogs Have Risen Sharply Deaths from fentanyl and fentanyl analogs, such as carfentanil, have more than doubled since 2015, the CDC reports. The increase is a result of increased supply of the drugs and their mixture with heroin.
  News Alerts, July 12, 2018
• ADA 2018 Liraglutide: A New Player in Type 1 Diabetes Treatment? In a randomized, placebo-controlled trial, liraglutide added to insulin improved glycemic control and reduced weight and blood pressure.
  Medscape Medical News, July 09, 2018
• ADA 2018 Investigational Tube-Free Pump for U-500 Insulin: A Viable Option The specially designed device by the makers of Omnipod may help avoid dosing errors in patients with type 2 diabetes requiring high doses of insulin.
  Medscape Medical News, July 05, 2018